Long-term efficacy and safety of biphasic insulin aspart in patients with type 2 diabetes
- 31 December 2004
- journal article
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 15 (8) , 496-502
- https://doi.org/10.1016/j.ejim.2004.10.001
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Interval between insulin injection and meal in relation to glycated haemoglobinPractical Diabetes International, 2001
- Clinical Pharmacokinetics and Pharmacodynamics of Insulin AspartClinical Pharmacokinetics, 2001
- Insulin aspart vs. human insulin in the management of long‐term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trialDiabetic Medicine, 2000
- Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes.Diabetes Care, 2000
- Comparative pharmacokinetics and pharmacodynamics of the novel rapid-acting insulin analogue, insulin aspart, in healthy volunteers.European Journal of Clinical Pharmacology, 1999
- Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group.Diabetes Care, 1998
- Do Insulin‐treated Diabetic Patients Use an Injection‐meal‐interval in Daily Life?Diabetic Medicine, 1995
- Action Profile of the Rapid Acting Insulin Analogue: Human Insulin B28AspDiabetic Medicine, 1993
- Monomeric Insulins and Their Experimental and Clinical ImplicationsDiabetes Care, 1990
- Monomeric insulins obtained by protein engineering and their medical implicationsNature, 1988